• FirefoxUpgrade to the new Firefox »
  •  Dow Down 0.06% Nasdaq Up 0.42%

    Nektar Therapeutics (NKTR)

    -NasdaqGS
    12.98 Down 0.24(1.82%) 4:00PM EST
    Add to Portfolio
    Prev Close:13.22
    Open:12.95
    Bid:12.61 x 1000
    Ask:14.30 x 300
    1y Target Est:18.43
    Beta:1.76
    Earnings Date:May 5 - May 11 (Est.)
    Day's Range:12.75 - 13.28
    52wk Range:10.10 - 17.53
    Volume:1,096,269
    Avg Vol (3m):1,018,560
    Market Cap:1.68B
    P/E (ttm):N/A
    EPS (ttm):-0.46
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for NKTR

    Comparison

    Symbol% ChgMkt Cap
    NKTRDown 1.82%1.68B
    BMYUp 0.39%102.15B
    ENZN 0.00%48.11M
    GSKUp 0.25%115.08B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):8.52
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.45
    Quarterly EPS Est (Mar-15) :-0.30
    Mean Recommendation*:1.8
    PEG Ratio (5 yr expected):-0.69

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Nektar Therapeutics, a clinical-stage biopharmaceutical company, develops drug candidates that utilize its PEGylation and polymer conjugate technology platforms in the United States. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback